1. buyermode474
2. RobinFromTheHood
3. ColoradoColo
1.buyermode474 01/19/2018
Phase Ib2 data announced
2.buyermode474 02/12/2018
Announces FDA has granted Orphan Drug Designation to its ABO-202 program
3.RobinFromTheHood 09/25/2017
Positive upward movement
4.RobinFromTheHood 09/25/2017
Way Undervalued Has very low expenses EPS=$10, SP=$100+. That is nearly $17 per share in sales along with Europe Based on $25 per share in sales along with Europe. FDA approval=$1.8B
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW